" /> Serine/Threonine Kinase Inhibitor CBP501 - CISMeF





Preferred Label : Serine/Threonine Kinase Inhibitor CBP501;

NCIt synonyms : Serine Threonine Kinase Inhibitor CBP501; D-Arginine, 4-Benzoyl-D-phenylalanyl-D-seryl-D-tryptophyl-D-seryl-2,3,4,5,6-pentafluoro-D-phenylalanyl-3-cyclohexyl-D-alanyl-D-arginyl-D- arginyl-D-arginyl-D-glutaminyl-D-arginyl-; Cdc25C Phosphatase (211-221);

NCIt related terms : CBP-501;

NCIt definition : A peptide with G2 checkpoint-abrogating activity. G2 checkpoint inhibitor CBP501 inhibits multiple serine/threonine kinases, including MAPKAP-K2, C-Tak1, and CHK1, that phosphorylate serine 216 of the dual-specific phosphatase Cdc25C (cell division checkpoint 25 C); disruption of Cdc25C activity results in the inhibition of Cdc25C dephosphorylation of the mitotic cyclin-dependent kinase complex Cdc2/cyclin B, preventing entry into the mitotic phase of the cell cycle.;

UNII : XH2662798I;

InChIKey : DEZJGRPRBZSAKI-KMGSDFBDSA-N;

CAS number : 565434-85-7;

Molecule name : CBP 501; CBP-501;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.